Inovio Pharma (INO) Misses Q3 EPS by 87c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.21 -6.92%
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q3 EPS of ($0.87).
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup set to join top banks in Anthropic IPO - Bloomberg
- UBS Downgrades Alkane Resources (ALK:AU) to Neutral
- Jefferies Downgrades Pop Mart International Group Ltd (9992:HK) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
